[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-292877-105":59,"doc-detail-292877-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pharmacare-newsletter-june-2023-edition-23-006","pharmacare newsletter june 2023 - edition 23-006","","PharmaCare Newsletter Edition 23-006 (June 2023) provides policy and coverage updates for B.C. pharmacists and clients. It details the move of opioid agonist treatment (OAT) coverage to Plan Z, including regular and exceptional pathways, and highlights potential coverage issues for non-benefit OAT Special Authority after June 6, 2023. The bulletin also outlines eligibility-related changes such as Paxlovid updates, prosthetic and orthotic program adjustments, and formulary and listing updates, alongside resources and service information.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pharmacare-newsletter-june-2023-edition-23-006/292877/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pharmacare-newsletter-june-2023-edition-23-006/292877.png","ImageObject",300,407,{"name":92,"@type":93},"Lute","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-17",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What changed on June 6, 2023 for opioid agonist treatment coverage?","Question",{"text":113,"@type":114},"Opioid agonist treatment (OAT) became covered under Plan Z for all B.C. residents. Exceptional Plan Z coverage is also available for residents not yet enrolled in the Medical Services Plan (MSP).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why might some patients with active non-benefit OAT Special Authority lose full coverage at the pharmacy?",{"text":118,"@type":114},"After June 6, 2023, patients may shift from 100% coverage to partial or no coverage despite an active SA approval. This can occur after an income review or a January 1 deductible update for people covered by Fair PharmaCare due to technical requirements for entering SAs to cover non-benefit OAT.",{"name":120,"@type":111,"acceptedAnswer":121},"What additional updates are included beyond OAT in this June 2023 newsletter edition?",{"text":122,"@type":114},"The newsletter covers items such as Paxlovid eligibility updates, prosthetic and orthotic policy changes, Scope of Practice Corner content, and service information for Minor Ailments and Contraception Service (MACS), including emergency contraception and related resources.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},292877,1790062567,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146},137454149569,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Edition 23-006: June 2023  \nTable of Contents  \nOpioid agonist treatment moves to Plan Z ............................................................................................2  \nPotential coverage issues for non-benefit OAT Special Authority .............................................................. 2  \nExceptional Plan Z coverage ........................................................................................................................ 2  \nPaxlovid eligibility update .....................................................................................................................3  \nProsthetic and orthotic policy changes..................................................................................................4  \nScope of Practice Corner .......................................................................................................................5  \nMinor Ailments and Contraception Service (MACS) .................................................................................... 5  \nEmergency contraception ........................................................................................................................... 5  \nInfo sheets: share the news! ....................................................................................................................... 5  \nSearch past PharmaCare newsletters ....................................................................................................6  \nRAT kit payment update .......................................................................................................................7  \nPolicy Spotlight: Prosthetic and Orthotic Program ................................................................................8  \nFormulary and listing updates ...............................................................................................................8  \nExpensive Drugs for Rare Diseases: tafamidis, triheptanoin ....................................................................... 8  \nLimited Coverage benefits: Semglee®, Elonox® .......................................................................................... 9  \nNon-benefits: cariprazine, mesalamine, ospemifene, prasterone ............................................................ 10  \nYour Voice: Input needed for drug decisions ....................................................................................... 10  \nPharmaCare Scripts: Minor Ailments and Contraception Service ........................................................ 11  \nSpecial Edition Newsletter June 1, 2023 .............................................................................................. 12  \nMinor Ailments and Contraception Service launches today ..................................................................... 12  \nResources .................................................................................................................................................. 12  \nSpecial Edition Newsletter June 21, 2023 ............................................................................................ 12  \nMinor Ailments and Contraception Service (MACS) booking system ....................................................... 12  \nBCPhA training materials and information session ................................................................................... 13  \nResources .................................................................................................................................................. 13  \nSpecial Edition Newsletter June 28, 2023 ............................................................................................ 13  \nMACS booking system ready for patients ................................................................................................. 13  \nInformation to share with pharmacy clients ............................................................................................. 13  \nExcept","cbCaigPsqSYX4adT","https://ap.wps.com/l/cbCaigPsqSYX4adT","pdf",870275,15,"English","# Opioid agonist treatment moves to Plan Z\n## Potential coverage issues for non-benefit OAT Special Authority\n## Exceptional Plan Z coverage\n# Paxlovid eligibility update\n# Prosthetic and orthotic policy changes\n# Scope of Practice Corner\n# Minor Ailments and Contraception Service (MACS)\n## Emergency contraception\n## Info sheets: share the news!\n# RAT kit payment update\n# Policy Spotlight: Prosthetic and Orthotic Program\n# Formulary and listing updates\n## Expensive Drugs for Rare Diseases: tafamidis, triheptanoin\n## Limited Coverage benefits: Semglee®, Elonox®\n## Non-benefits: cariprazine, mesalamine, ospemifene, prasterone\n# Your Voice: Input needed for drug decisions\n# PharmaCare Scripts: Minor Ailments and Contraception Service\n# Special Edition Newsletter June 1, 2023\n# Special Edition Newsletter June 21, 2023\n# Special Edition Newsletter June 28, 2023\n# Resources","[{\"question\":\"What changed on June 6, 2023 for opioid agonist treatment coverage?\",\"answer\":\"Opioid agonist treatment (OAT) became covered under Plan Z for all B.C. residents. Exceptional Plan Z coverage is also available for residents not yet enrolled in the Medical Services Plan (MSP).\"},{\"question\":\"Why might some patients with active non-benefit OAT Special Authority lose full coverage at the pharmacy?\",\"answer\":\"After June 6, 2023, patients may shift from 100% coverage to partial or no coverage despite an active SA approval. This can occur after an income review or a January 1 deductible update for people covered by Fair PharmaCare due to technical requirements for entering SAs to cover non-benefit OAT.\"},{\"question\":\"What additional updates are included beyond OAT in this June 2023 newsletter edition?\",\"answer\":\"The newsletter covers items such as Paxlovid eligibility updates, prosthetic and orthotic policy changes, Scope of Practice Corner content, and service information for Minor Ailments and Contraception Service (MACS), including emergency contraception and related resources.\"}]","pharmacare newsletter june 2023 - edition 23-006 | PDF",1789657019,38]